Evoke Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 05/13/2022 | 1.12 M | $553,000 | -0.71% | 3.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2022 | 222,948 | $110,000 | 6.11% | 0.68% |
| BLACKROCK INC. | 05/12/2022 | 177,127 | $88,000 | -1.78% | 0.54% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 05/11/2022 | 108,545 | $54,000 | 0.00% | 0.33% |
| STATE STREET CORP | 05/16/2022 | 82,645 | $41,000 | 13.52% | 0.25% |
| CORNERSTONE CAPITAL, INC. | 05/13/2022 | 66,000 | $33,000 | 100.00% | 0.20% |
| VIRTU FINANCIAL LLC | 05/17/2022 | 42,793 | $21,000 | -22.67% | 0.13% |
| NORTHERN TRUST CORP | 05/13/2022 | 42,121 | $21,000 | 0.00% | 0.13% |
| WAMBOLT & ASSOCIATES, LLC | 05/10/2022 | 32,000 | $15,000 | 0.00% | 0.10% |
| RENAISSANCE TECHNOLOGIES LLC | 05/13/2022 | 28,200 | $14,000 | -38.07% | 0.09% |
| UBS GROUP AG | 05/16/2022 | 24,717 | $12,000 | 591.77% | 0.08% |
| PURE FINANCIAL ADVISORS, LLC | 04/12/2022 | 17,647 | $9,000 | 0.00% | 0.05% |
| LAIRD NORTON TRUST COMPANY, LLC | 05/06/2022 | 11,000 | $5,000 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/12/2022 | 10,807 | $5,000 | 159.97% | 0.03% |
| MORGAN STANLEY | 10/27/2022 | 6,224 | $3,000 | -35.21% | 0.02% |
| SPIRE WEALTH MANAGEMENT | 04/18/2022 | 5,000 | $2,000 | 0.00% | 0.02% |
| SIMPLEX TRADING, LLC | 05/02/2022 | 3,042 | $1,000 | 29.89% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 05/04/2022 | 500 | $0 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/16/2022 | 185 | $0 | 1.09% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/15/2024 | 60 | $30 | 0.00% | 0.00% |
| FMR LLC | 05/13/2022 | 47 | $0 | -68.46% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/16/2022 | 0 | $0 | -100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/09/2022 | 0 | $0 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/12/2022 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/16/2022 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2022 | 0 | $0 | -100.00% | 0.00% |
| SABBY MANAGEMENT, LLC | 05/16/2022 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/17/2022 | 0 | $0 | -100.00% | 0.00% |
| LINDBROOK CAPITAL, LLC | 04/21/2022 | 0 | $0 | -100.00% | 0.00% |
Evoke Pharma, Inc.institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of Evoke Pharma, Inc.. The most heavily invested institutionals were:
Acrospire Investment Management LLC: 0
Commonwealth Equity Services, Inc: 30,062
Virtu KCG Holdings LLC: 0
BlackRock Fund Advisors: 31,132
BlackRock Investment Management, LLC: 1,285
UBS AG: 265
6.09% of Evoke Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 102,647 shares in the last 24 months. This purchase volume represents approximately $476,282 in transactions.